4 Stocks to Sell Now, Until the Fed Acts

Photo of Trey Thoelcke
By Trey Thoelcke Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Monday was historic. The Dow Jones had a 7% intraday trading range. The Nasdaq was even more volatile with a 9% intraday trading range. The S&P 500 had gained more than 2% in the space of 12 minutes at one point, and still closed down 4%.

These types of movements are not one offs. They usually come in clusters. And it is very likely that, until the Federal Reserve reassures markets that a rate hike is absolutely off the table, the bottom is not in yet. An announcement of “QE4” may even be necessary. That said, here are four stocks that investors should sell now, especially if the markets open gap up Tuesday morning.

Alibaba

Alibaba Group Holding Ltd. (NYSE: BABA) is not only merely associated with China in the minds of traders, 82% of its revenues come from Chinese commerce. The Chinese yuan supply has increased by a factor of five in 10 years. The rate of increase is now stalling, which is what brings on busts after huge booms. No other central bank has printed more money than China has, with the exception of Venezuela, which is currently in the throes of hyperinflation. The Fed does not even come close to the People’s Bank of China in terms of money supply expansion. The Chinese stock market crash could be the biggest in history, considering the amount of money that has fueled it. That will bleed into the Chinese economy soon, which will bring Alibaba down with it.

Alibaba shares were up about 4% in Tuesday’s premarket to $68.41.

ALSO READ: 5 Defensive High-Yield Stocks to Survive the Sell-Off Carnage

HomeAway

HomeAway Inc. (NASDAQ: AWAY) is a competitor of Airbnb, matching vacationers with owners of vacation rentals. There is nothing wrong with the business. It makes money. The problem is the valuation. With a market cap of $2.6 billion, its price-to-earnings ratio is over 27,000. Traders are either expecting it to grow by orders of magnitude, or they are just buying it to sell to someone else at a higher price. More likely the latter. Traders stop trying to do that when the trend reverses.

Shares were inactive in premarket trading, after closing at $27.28, down 6.6% on Monday.

Netflix

Netflix Inc. (NASDAQ: NFLX) is a good company with good fundamentals. The only problem is, what has driven its stock price is not those fundamentals. The main thing that has driven it higher is the fact that it has been going higher. It is a positive feedback loop that is only sustained by money printing and zero interest rates. The new money finds something that it can trade for a profit and looks for winners. Netflix just happened to be one of the targets this time. Momentum stocks do not just stall. They continue to be momentum stocks, just in the other direction, until the parabola breaks, like a clean-up hitter and a fast ball.

Shares of Netflix were 8.2% higher in Tuesday’s premarket to $104.80.

Regeneron

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is the Netflix of biotech, except it is less stable. Biotech has led stocks higher. Regeneron has led biotech in terms of stratospheric valuations. That valuation has been led higher by a single drug, a one-hit wonder called Eylea. The Regeneron parabola seems to have already topped, and it still has a price to earnings of 125. When investors realize that a single product does not justify such a price, and a wave of broad-based panic selling tends help with this process by bringing people to their senses, it could fall even faster.

In Tuesday’s premarket, Regeneron was up 3% to $520.01 per share.

ALSO READ: Where Will Warren Buffett Put Money as Markets Collapse?

All this applies as long as the Fed stays quiet. Any sign that they are considering more quantitative easing though, and trends can continue up, pushing all these stock even higher. It was QE that made most of this happen, and only QE can keep it going.

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618